Eric Mazanek

Eric Mazanek is currently the Associate Director of Corporate Accounts at CSL, specializing in National Accounts for rare diseases and biotherapy launch and reimbursement management. Eric has extensive experience in the pharmaceutical industry, previously serving as National Account Director at Amylyx Pharmaceuticals and Director of National Accounts at Flexion Therapeutics. They have held various roles, including Corporate Account Director at Mallinckrodt Pharmaceuticals and Senior Specialty Sales Representative at Jazz Pharmaceuticals. Eric earned a Bachelor of Science in Education/Biology from Duquesne University and is a graduate of The Kiski School.